AbbVie Inc. is 3.6x more valuable than VERTEX PHARMACEUTICALS INC / MA by market capitalization ($399.47 B vs $110.46 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | VRTX | ABBV |
|---|---|---|
| Market cap | $110.46 B | $399.47 B |
| US-listed rank | #136 | #28 |
| Revenue (latest FY) | $12.00B | $61.16B |
| Net income (latest FY) | $3.95B | $4.23B |
| Net margin | 32.9% | 6.9% |
| P/E (trailing FY) | 27.9 | 94.5 |
| SEC filings | 1,000 | 1,008 |
AbbVie Inc. is 3.6x more valuable than VERTEX PHARMACEUTICALS INC / MA by market capitalization ($399.47 B vs $110.46 B).
In their latest fiscal years, VERTEX PHARMACEUTICALS INC / MA reported $12.00B in revenue while AbbVie Inc. reported $61.16B.
Full pages: VERTEX PHARMACEUTICALS INC / MA and AbbVie Inc., or browse the full rankings.